Patent · US Active

Chemical compounds

US8203001B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Ulrich Reiser · Wien, AT
Peter Ettmayer · Wien, AT
Oliver Kraemer · Wien, AT
Peter Sennhenn · Munich, DE
Walter Spevak · Stockerau, AT

Key dates

Filing date	Jun 13, 2007
Grant date	Jun 19, 2012
Priority date	—
Expiry date	Jun 13, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention encompasses compounds of general formula (1) wherein R1, M1, L1 and Q are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or anomalous cell proliferation, and the use thereof for preparing a pharmaceutical composition with the above-mentioned properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.